The use of beebread-honey mixture in the treatment of liver diseases in alcohol-dependent patients


  • V. Čeksterytė Lithuanian Research Centre for Agriculture and Forestry, Institute of Agriculture
  • J. Balžekas Lithuanian Research Centre for Agriculture and Forestry, Institute of Agriculture
  • A. Baltuškevičius Republic Hospital of Kaunas
  • E. Jurgevičius Republic Hospital of Kaunas



Liver disorders are associated with the high fat diet, high level of cholesterol, excessive alcohol consumption and hepatic viruses.

The objective of the current study was to determine the effect of beebread mixed with honey on the hepatic function and blood parameters in alcohol abuse patients suffering from chronic hepatitis.

Materials and methods. Eighteen patients (5 females and 13 males) aged between 19–69 years were involved in the study on chronic hepatitis treatment. Fifteen patients were treated in hospital after flare-up of alcohol-induced hepatitis; for one patient liver disease was caused by obesity and one was drug-induced. Patients’ blood samples were analysed for erythrocytes, hemoglobin, leukocytes, C-reactive protein (CRP) glucose, and bilirubin, liver enzymes aspartate aminotransferase (AST) and alanine aminotransferase (ALT). The patients received medical treatment with Hepatil and nutritional supplement Livosan, containing 83.33 mg milk thistle (Silybum marianum) extract, produced by the Lithuanian pharmaceutical company „Aconitum“, and beebread mixed with honey (1 : 2) at 15 grams twice a day after a meal. The data were compared with those of the control group (4 females and 6 males), treated with only medicaments. The average treatment period was 5 weeks.

Statistically significant reduction in CRP, AST, bilirubin and a trend towards reduction of ALT levels after treatment was recorded for the group of patients who had received medicaments, Livosan and bee bread mixed with honey. Beebread used together with medicaments and supplement Livosan exerted hepatoprotective effect and improved liver function.